MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.

Inge Kortekaas KrohnI CallebautYeranddy A AlpizarB SteelantLaura Van GervenP S SkovA KasranK TalaveraM M WoutersJ L CeuppensS F SeysP W Hellings

Published in: Allergy (2018)

MP29-02 treatment reduces inflammatory mediators and NHR in AR. The effects of AZE + FP on MC degranulation, nasal epithelial barrier integrity, and TRP channels provide novel insights into the pathophysiology of allergic rhinitis.

Keyphrases

allergic rhinitis
chronic rhinosinusitis
oxidative stress
human health
health risk assessment
drinking water